IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 217 filers reported holding IMMUNOGEN INC in Q2 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,795,341 | -63.0% | 113,128 | -56.1% | 0.07% | -62.3% |
| Q2 2023 | $4,857,478 | +5711.4% | 257,418 | +1082.6% | 0.18% | +6000.0% |
| Q1 2023 | $83,585 | +22.0% | 21,767 | +57.6% | 0.00% | -25.0% |
| Q4 2022 | $68,517 | -93.5% | 13,814 | -93.7% | 0.00% | -90.2% |
| Q3 2022 | $1,048,000 | +638.0% | 219,140 | +593.0% | 0.04% | +583.3% |
| Q2 2022 | $142,000 | -27.6% | 31,621 | -23.1% | 0.01% | -25.0% |
| Q1 2022 | $196,000 | -64.6% | 41,146 | -44.8% | 0.01% | -77.1% |
| Q4 2021 | $553,000 | +870.2% | 74,500 | +641.4% | 0.04% | +775.0% |
| Q3 2021 | $57,000 | -83.2% | 10,048 | -76.0% | 0.00% | -87.5% |
| Q1 2021 | $339,000 | – | 41,890 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |